Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions

JAMA

Volumn 289, Issue 15, 2003, Pages 1941-1949

  Hébert, Paul C ^a   Fergusson, Dean ^a   Blajchman, Morris A ^b   Wells, George A ^a   Kmetic, Andrew ^a   Coyle, Doug ^a   Heddle, Nancy ^b   Germain, Marc ^c   Goldman, Mindy ^c   Toye, Baldwin ^d   Schweitzer, Irwin ^a   Van Walraven, Carl ^a   Devine, Dana ^e   Sher, Graham D ^e  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HÉMA QUÉBEC   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BIRTH WEIGHT; BLOOD FILTRATION; CANADA; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEART SURGERY; HIGH RISK PATIENT; HIP FRACTURE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LEUKOCYTE; LEUKOREDUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE TRAUMA; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; BLOOD BANK; CELL SEPARATION; CLINICAL TRIAL; CROSS INFECTION; FILTRATION; INTENSIVE CARE UNIT; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE HEMORRHAGE; STANDARD;

ADULT; AGED; BLOOD BANKS; CANADA; CELL SEPARATION; CROSS INFECTION; ERYTHROCYTE TRANSFUSION; FEMALE; FILTRATION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTES; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES;

EID: 0242578548     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.15.1941     Document Type: Article

References (30)

1. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion. 1993;33:754-765.
2. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion. 1997;37:121-125.
3. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253-259.
4. Houbiers JGA, Brand A, van de Watering LMG, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994;344:573-578.
5. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996;348:841-845.
6. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97:562-568.
7. Bilgin YM, van de Watering LM, Lorinser JE, et al. The effects of prestorage leukocyte-depletion of erytrocyte concentrates in cardiac surgery: a double-blind randomised clinical trial. Blood. 2001;98(suppl):828a-829a.
8. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg. 1998;85:171-178.
9. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case forand against. Transfusion. 2001;41:691-712.
10. Thurer RL, Luban NLC, Aubuchon JP, et al. Universal WBC reduction. Transfusion. 2000;40:751-752.
11. Chiavetta JA, Herst R, Freedman J, Axcell TJ, Wall AJ, Van Rooy SC. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion. 1996;36:699-706.
12. Hébert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med. 1997;155:1618-1623.
13. Canadian Blood Services. Circular of information for the use of human blood and blood components [pamphlet]. Ottawa, Ontario: Canadian Blood Services, 2002.
14. PALL Medical. Leukotrap WB CPDA-1 & Nutricel [pamphlet]. East Hills, NY: Pall Medical Blood Processing Group; 2002.
15. Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-706.
16. Toews GB. Nosocomial pneumonia. Clin Chest Med. 1987;8:467-479.
17. Members of ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
18. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA. 1995;274:968-974.
19. Knaus WA, Sun X, Nystrom P-O, Wagner DP. Evaluation of definitions for sepsis. Chest. 1992;101:1656-1662.
20. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606-608.
21. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
22. Society for Hospital Epidemiology of America, Association for Practitioners in Infection Control, Centers for Disease Control and Prevention, Surgical Infection Society. Consensus paper on the surveillance of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:599-605.
23. Yusuf S, Sleight P, Pogue J, Bosch J, Dagenais G, for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-153.
24. Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP. A prospective, randomized clinical trial of universal WBC reduction. Transfusion. 2002;42:1114-1122.
25. Baron J-F, Gourdin M, Bertrand M, et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg. 2002;94:529-539.
26. Weiss SJ. Tissue destruction by neutrophils [abstract]. N Engl J Med. 1989;320:365-376.
27. Welbourn C, Goldman G, Paterson IS, Valeri C, Shepro D, Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil [abstract]. Br J Surg. 1991;78:651-655.
28. Moore FA, Moore EE, Sauaia A. Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132:620-625.
29. Shanwell A, Kristiansson M, Remberger M, Ringden O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 1997;37:678-684.
30. Fergusson DA, Hébert PC, Shapiro S. The before/after study design in transfusion medicine: methodologic considerations. Transfus Med Rev. 2002;16:296-303.